Product Information
CLOBETASOL 0.05% OINTMENT is a generic product labeled by Xiromed LLC, priced at $0.1146 per GM under NDC 70700010617. Its NADAC has been published 412 times since Nov 14, 2018.
FDA first approved this application on Apr 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Xiromed LLCNDC
70700010617
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA209701FDA Approved
4/17/2018
TE Code
AB
On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% OINTMENT has been published 412 times since Nov 14, 2018, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1146 per GM |
|---|---|
| All-time high | $0.8366 (Nov 14, 2018) |
| All-time low | $0.0970 (Nov 20, 2024) |
| 52-week high | $0.1312 |
| 52-week low | $0.1101 |
| Median price | $0.1981 |
| Average price | $0.3036 |
| Largest weekly change | +50.1% (Dec 23, 2020) |
| Weeks tracked | 412 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clobetasol propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% OINTMENT, manufactured by Xiromed LLC, is $0.1146 per GM (NDC 70700010617), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% OINTMENT changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% OINTMENT has declined 86.3%. It has been tracked across 412 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% OINTMENT?
Since Nov 14, 2018, the NADAC for CLOBETASOL 0.05% OINTMENT has ranged from a low of $0.0970 (Nov 20, 2024) to a high of $0.8366 (Nov 14, 2018), with a median of $0.1981 per GM.
Are there cheaper alternatives to CLOBETASOL 0.05% OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% OINTMENT, is $0.1083 per GM — about 5% below CLOBETASOL 0.05% OINTMENT.
Who manufactures CLOBETASOL 0.05% OINTMENT?
CLOBETASOL 0.05% OINTMENT (NDC 70700010617) is labeled by Xiromed LLC, and CMS classifies it as a generic product.